1.       Research Framework

1.1.    Research Objective

1.2.    Market Overview

1.3.    Market Segmentation

2.       Research Methodology

2.1.    Qualitative Research

2.1.1. Primary & Secondary Research

2.2.    Quantitative Research

2.3.    Market Breakdown & Data Triangulation

2.3.1. Secondary Research

2.3.2. Primary Research

2.4.    Breakdown of Primary Research Respondents, By Region

2.5.    Assumption & Limitation

3.       Executive Summary

4.       Global Real-World Evidence Solution Market Insights

4.1.    DROC Analysis

4.1.1. Growth Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.1.4. Challenges

4.2.    Recent Development

4.3.    Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Intensity of Rivalry

4.4.    Industry Value Chain Analysis

5.       Global Real-World Evidence Solution Market Overview

5.1.    Market Size & Forecast by Value, 2016-2027

5.1.1. By Value (USD Million)

5.2.    Market Share & Forecaste

5.2.1. By Therapeutic Area

5.2.1.1.              Cardiovascular

5.2.1.2.              Oncology

5.2.1.3.              Immunology

5.2.1.4.              Others

5.2.2.  By Component

5.2.2.1.              Data Set

5.2.2.1.1.                    Clinical Setting Data

5.2.2.1.2.                    Claims Data

5.2.2.1.3.                    Pharmacy

5.2.2.1.4.                    Patient Powered Data

5.2.2.2.              Services

5.2.3. By End-User

5.2.3.1.              Medical Devices

5.2.3.2.              Payers

5.2.3.3.              Pharmaceuticals

5.2.3.4.              Providers

5.2.4. By Region

5.2.4.1.           North America

5.2.4.2.           Europe

5.2.4.3.           Asia Pacific

5.2.4.4.           Latin America

5.2.4.5.           Middle East & Africa

6.       North America Real-World Evidence Solution Market  

6.1.    Market Size & Forecast by Value, 2016-2027

6.1.1. By Value (USD Million)

6.2.    Market Share & Forecast

6.2.1. By Therapeutic Area

6.2.2. By Component

6.2.3. By End-User

6.2.4. By Country

6.2.4.1.           United States

6.2.4.2.           Canada

6.2.4.3.           Rest of North America

7.       Europe Real-World Evidence Solution Market

7.1.    Market Size & Forecast by Value, 2016-2027

7.1.1. By Value (USD Million)

7.2.    Market Share & Forecast

7.2.1. By Therapeutic Area

7.2.2. By Component

7.2.3. By End-User

7.2.4. By Country

7.2.4.1.              Germany

7.2.4.2.              France

7.2.4.3.              United Kingdom

7.2.4.4.              Italy

7.2.4.5.              Rest of Europe

8.       Asia Pacific Real-World Evidence Solution Market

8.1.    Market Size & Forecast by Value, 2016-2027

8.1.1. By Value (USD Million)

8.2.    Market Share & Forecast

8.2.1. By Therapeutic Area

8.2.2. By Component

8.2.3. By End-User

8.2.4. By Country

8.2.4.1.           China

8.2.4.2.           India

8.2.4.3.           Japan

8.2.4.4.           Rest of Asia Pacific

9.       Latin America Real-World Evidence Solution Market

9.1.    Market Size & Forecast by Value, 2016-2027

9.1.1. By Value (USD Million)

9.2.    Market Share & Forecast

9.2.1. By Therapeutic Area

9.2.2. By Component

9.2.3. By End-User

9.2.4. By Component

9.2.5. By Country

9.2.5.1.           Brazil

9.2.5.2.           Mexico

9.2.5.3.           Argentina

9.2.5.4.           Rest of Latin America

10.   Middle East & Africa Real-World Evidence Solution Market

10.1.  Market Size & Forecast by Value, 2016-2027

10.1.1.                     By Value (USD Million)

10.2.          Market Share & Forecast

10.2.1.                     By Therapeutic Area

10.2.2.                     By Component

10.2.3.                     By End-User

10.2.4.                     By Component

10.2.5.                     By Country

10.2.5.1.             Saudi Arabia

10.2.5.2.             UAE

10.2.5.3.             South Africa

10.2.5.4.             Rest of Middle East & Africa

11.   Competitive Landscape

11.1.          List of Key Players and Their Offerings

11.2.          Market/Ranking Share Analysis

11.3.          Competitive Benchmarking, By Operating Parameters

12.   Impact of COVID on Global Real-World Evidence Solution Market

12.1.  Impact On Overall Real-World Evidence Solution Industry

12.2.  Impact On End-Users

13.   Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook) *

13.1.          Anthem, Inc.

13.2.          Clinigen Group plc

13.3.          Cognizant Technology Solutions Corporation

13.4.          International Business Machines (IBM) Corporation

13.5.          ICON Public Limited

13.6.          Quintiles IMS Holdings, Inc.

13.7.          UnitedHealth Group

13.8.          Oracle Corporation

13.9.          PAREXEL International Corporation

13.10.      PerkinElmer, Inc.

13.11.      Other Prominent Players

List of Figures

Fig: Global Real-World Evidence Solution Segmentation

Fig: Global Real-World Evidence Solution Market Value Chain Analysis

Fig: Company Market Share Analysis, 2019

Fig: Global Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: Global Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: Global Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: Global Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Fig: Global Real-World Evidence Solution Market Share, By Region, By Value, 2016-2027

Fig: North America Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: North America Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: North America Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: North America Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Fig: North America Real-World Evidence Solution Market Share, By Country, By Value, 2016-2027

Fig: Europe Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: Europe Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: Europe Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: Europe Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Fig: Europe Real-World Evidence Solution Market Share, By Country, By Value, 2016-2027

Fig: Asia-Pacific Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: Asia-Pacific Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: Asia-Pacific Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: Asia-Pacific Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Fig: Asia-Pacific Real-World Evidence Solution Market Share, By Country, By Value, 2016-2027

Fig: Latin America Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: Latin America Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: Latin America Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: Latin America Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Fig: Latin America Real-World Evidence Solution Market Share, By Country, By Value, 2016-2027

Fig: Middle East & Africa Real-World Evidence Solution Market Size, By Value (USD Million), 2016-2027

Fig: Middle East & Africa Real-World Evidence Solution Market Share, By Therapeutic Area, By Value, 2016-2027

Fig: Middle East & Africa Real-World Evidence Solution Market Share, By Component, By Value, 2016-2027 Fig: Middle East & Africa Real-World Evidence Solution Market Share, By End-User , By Value, 2016-2027

Fig: Middle East & Africa Real-World Evidence Solution Market Share, By Country, By Value, 2016-2027

 

 

List of Tables

 

Table: Global Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: Global Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: Global Real-World Evidence Solution Market Size, By End-User, By Value, 2016-2027

Table: Global Real-World Evidence Solution Market Size, By Region, By Value, 2016-2027

Table: North America Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: North America Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: North America Real-World Evidence Solution Market Size, By End-User, By Value, 2016-2027

Table: North America Real-World Evidence Solution Market Size, By Country, By Value, 2016-2027

Table: Europe Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: Europe Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: Europe Real-World Evidence Solution Market Size, By End-User, By Value, 2016-2027

Table: Europe Real-World Evidence Solution Market Size, By Country, By Value, 2016-2027

Table: Asia-Pacific Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: Asia-Pacific Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: Asia-Pacific Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Table: Asia-Pacific Real-World Evidence Solution Market Size, By Country, By Value, 2016-2027

Table: Latin America Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: Latin America Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: Latin America Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Table: Latin America Real-World Evidence Solution Market Size, By Country, By Value, 2016-2027

Table: Middle East & Africa Real-World Evidence Solution Market Size, By Therapeutic Area, By Value, 2016-2027

Table: Middle East & Africa Real-World Evidence Solution Market Size, By Component, By Value, 2016-2027

Table: Middle East & Africa Real-World Evidence Solution Market Share, By End-User, By Value, 2016-2027

Table: Middle East & Africa Real-World Evidence Solution Market Size, By Country, By Value, 2016-2027

Table:  Anthem, Inc. Financial Analysis

Table:   Clinigen Group plc Financial Analysis

Table:   Cognizant Technology Solutions Corporation. Financial Analysis

Table:   International Business Machines (IBM) Corporation Financial Analysis

Table:   ICON Public Limited. Financial Analysis

Table:   UnitedHealth GroupFinancial Analysis

Table:   Oracle Corporation, Inc Financial Analysis

Table:   Quintiles IMS Holdings, Inc.Financial Analysis

Table:   PAREXEL International Corporation Financial Analysis

Table:   PerkinElmer, Inc. Financial Analysis